Andrew G Sikora

Summary

Publications

  1. doi request reprint Bidirectional association of anogenital and oral cavity/pharyngeal carcinomas in men
    Andrew G Sikora
    Department of Otolaryngology, Mount Sinai School of Medicine, One Gustave L Levy Place, Box 1189, New York, NY 10029, USA
    Arch Otolaryngol Head Neck Surg 135:402-5. 2009
  2. pmc Anatomic sites at elevated risk of second primary cancer after an index head and neck cancer
    Luc G T Morris
    Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Cancer Causes Control 22:671-9. 2011
  3. doi request reprint Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer
    Kunal S Jain
    Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Cancer 119:1832-7. 2013
  4. doi request reprint Prognostic significance of p16 in locoregionally advanced head and neck cancer treated with concurrent 5-fluorouracil, hydroxyurea, cetuximab and intensity-modulated radiation therapy
    Charles C L Tong
    Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA
    Oncol Rep 27:1580-6. 2012
  5. pmc Predictors of survival in mucosal melanoma of the head and neck
    Daniel Jethanamest
    Department of Otolaryngology Head and Neck Surgery, New York University School of Medicine, New York, NY, USA
    Ann Surg Oncol 18:2748-56. 2011
  6. pmc Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer
    Luc G T Morris
    Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    J Clin Oncol 29:739-46. 2011
  7. doi request reprint Recognizing and reversing the immunosuppressive tumor microenvironment of head and neck cancer
    Charles C L Tong
    Department of Otolaryngology, Head and Neck Surgery, The Mount Sinai School of Medicine, One Gustave L Levy Place, Box 1189, New York, NY, USA
    Immunol Res 54:266-74. 2012
  8. pmc Discrimination of benign and neoplastic mucosa with a high-resolution microendoscope (HRME) in head and neck cancer
    Peter M Vila
    Department of Otolaryngology Head and Neck Surgery, Mount Sinai School of Medicine, New York, NY, USA
    Ann Surg Oncol 19:3534-9. 2012
  9. pmc Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release
    Padmini Jayaraman
    Department of Otolaryngology, Mount Sinai School of Medicine, New York, NY 10028, USA
    J Immunol 188:5365-76. 2012
  10. doi request reprint Conference scene: immune effector mechanisms in tumor immunity
    Andrew G Sikora
    Departments of Otolaryngology, Immunology, Oncological Sciences and Dermatology, Mount Sinai School of Medicine, New York, NY 10029, USA
    Immunotherapy 4:141-3. 2012

Collaborators

Detail Information

Publications22

  1. doi request reprint Bidirectional association of anogenital and oral cavity/pharyngeal carcinomas in men
    Andrew G Sikora
    Department of Otolaryngology, Mount Sinai School of Medicine, One Gustave L Levy Place, Box 1189, New York, NY 10029, USA
    Arch Otolaryngol Head Neck Surg 135:402-5. 2009
    ..To test the hypothesis of a bidirectional association of anogenital and oral cavity/pharyngeal human papillomavirus (HPV)-associated cancers in men...
  2. pmc Anatomic sites at elevated risk of second primary cancer after an index head and neck cancer
    Luc G T Morris
    Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Cancer Causes Control 22:671-9. 2011
    ..Our objectives were to quantify the excess risk of SPM across all anatomic sites in which SPM risk is meaningfully elevated, including non-HNLE sites, in a large cohort of US patients...
  3. doi request reprint Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer
    Kunal S Jain
    Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Cancer 119:1832-7. 2013
    ....
  4. doi request reprint Prognostic significance of p16 in locoregionally advanced head and neck cancer treated with concurrent 5-fluorouracil, hydroxyurea, cetuximab and intensity-modulated radiation therapy
    Charles C L Tong
    Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA
    Oncol Rep 27:1580-6. 2012
    ..The most common grade 3-4 toxicities were mucositis (46%), leukopenia (18%), anemia (18%) and dermatitis (17%). Concurrent 5-FU, HU, cetuximab and SIB-IMRT is a highly active regimen, particularly in patients with p16-positive disease...
  5. pmc Predictors of survival in mucosal melanoma of the head and neck
    Daniel Jethanamest
    Department of Otolaryngology Head and Neck Surgery, New York University School of Medicine, New York, NY, USA
    Ann Surg Oncol 18:2748-56. 2011
    ..In order to identify factors predictive of survival, we analyzed MMHN outcomes in a large US cohort...
  6. pmc Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer
    Luc G T Morris
    Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    J Clin Oncol 29:739-46. 2011
    ..Our objectives were to identify HNSCC subsite-specific differences in SPM risk and distribution and to describe trends in risk over 3 decades, before and during the era of human papillomavirus (HPV) -associated oropharyngeal SCC...
  7. doi request reprint Recognizing and reversing the immunosuppressive tumor microenvironment of head and neck cancer
    Charles C L Tong
    Department of Otolaryngology, Head and Neck Surgery, The Mount Sinai School of Medicine, One Gustave L Levy Place, Box 1189, New York, NY, USA
    Immunol Res 54:266-74. 2012
    ..This article outlines significant immune-suppressive mechanisms in the HNSCC tumor microenvironment and potential approaches to enhancing the antitumor immune response...
  8. pmc Discrimination of benign and neoplastic mucosa with a high-resolution microendoscope (HRME) in head and neck cancer
    Peter M Vila
    Department of Otolaryngology Head and Neck Surgery, Mount Sinai School of Medicine, New York, NY, USA
    Ann Surg Oncol 19:3534-9. 2012
    ..Our goal was to determine the accuracy and inter-rater reliability of head and neck cancer specialists using high-resolution microendoscopic (HRME) images to discriminate between cancerous and benign mucosa...
  9. pmc Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release
    Padmini Jayaraman
    Department of Otolaryngology, Mount Sinai School of Medicine, New York, NY 10028, USA
    J Immunol 188:5365-76. 2012
    ..These data suggest a critical role for tumor-expressed iNOS in the recruitment and induction of functional MDSC by modulation of tumor VEGF secretion and upregulation of STAT3 and ROS in MDSC...
  10. doi request reprint Conference scene: immune effector mechanisms in tumor immunity
    Andrew G Sikora
    Departments of Otolaryngology, Immunology, Oncological Sciences and Dermatology, Mount Sinai School of Medicine, New York, NY 10029, USA
    Immunotherapy 4:141-3. 2012
    ..The conference built on these early successes and aimed to push further into the uncharted territories of successful cancer immunotherapy...
  11. pmc Tall-cell variant of papillary thyroid carcinoma: a matched-pair analysis of survival
    Luc G T Morris
    Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Thyroid 20:153-8. 2010
    ..Our objective was to utilize a large cancer registry to obtain sufficient power to differentiate between outcomes in cases of TCV and PTC...
  12. ncbi request reprint Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors
    Daniel Jethanamest
    Department of Otolaryngology, New York University School of Medicine, New York, NY, USA
    Arch Otolaryngol Head Neck Surg 133:276-80. 2007
    ..To investigate the characteristics associated with survival in esthesioneuroblastoma and to determine whether the modified Kadish staging system can predict outcome...
  13. ncbi request reprint Tamoxifen therapy for aggressive fibromatosis of the posterior triangle of the neck
    Luc G Morris
    Division of Head and Neck Surgery and Oncology, Department of Otolaryngology, New York University School of Medicine, New York, NY 1016, USA
    Otolaryngol Head Neck Surg 136:674-6. 2007
  14. pmc Targeting immune suppressing myeloid-derived suppressor cells in oncology
    Johnny Kao
    Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, United States
    Crit Rev Oncol Hematol 77:12-9. 2011
    ..Since c-kit can be readily inhibited by several small molecule inhibitors including imatinib, sunitinib and dasatinib, targeting immune suppressing cells can be readily accomplished in the clinic...
  15. doi request reprint The basis of racial differences in the incidence of thyroid cancer
    Luc G T Morris
    Head and Neck Service, Department of Otolaryngology, New York University Cancer Institute, New York University School of Medicine, New York, NY, USA
    Ann Surg Oncol 15:1169-76. 2008
    ..The incidence of thyroid cancer in black Americans is half that in white Americans. It is unknown whether this gap represents a population difference in disease or is attributable to inferior cancer screening in the black population...
  16. pmc Optical imaging with a high-resolution microendoscope to identify cholesteatoma of the middle ear
    Lauren L Levy
    Department of Otolaryngology Head and Neck Surgery, Mount Sinai School of Medicine, New York, New York 10029, USA
    Laryngoscope 123:1016-20. 2013
    ....
  17. doi request reprint HPV-induced oropharyngeal cancer, immune response and response to therapy
    Ha Linh Vu
    Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY, United States
    Cancer Lett 288:149-55. 2010
    ..This article outlines several mechanisms whereby the observed improved response of HPV-positive tumors to radiotherapy may be related to enhancement of the immune response following radiotherapy...
  18. doi request reprint Transoral robotic resection and reconstruction for head and neck cancer
    Eric M Genden
    Mount Sinai School of Medicine, Department of Otolaryngology Head and Neck Surgery, New York, New York 10029, USA
    Laryngoscope 121:1668-74. 2011
    ..To evaluate the patterns of failure, survival, and functional outcomes for patients treated with transoral robotic surgery (TORS) and compare these results with those from a cohort of patients treated with concurrent chemoradiation (CRT)...
  19. pmc The increasing incidence of thyroid cancer: the influence of access to care
    Luc G T Morris
    Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Thyroid 23:885-91. 2013
    ..To conclude that overdiagnosis is occurring, evidence for an association between access to health care and the incidence of cancer is necessary...
  20. ncbi request reprint Oropharyngeal kaposi sarcoma in related persons negative for human immunodeficiency virus
    Andrew G Sikora
    Department of Otolaryngology Head and Neck Surgery, New York University School of Medicine, New York, New York, USA
    Ann Otol Rhinol Laryngol 117:172-6. 2008
    ..We describe an unusual presentation of KS in 2 related individuals and describe our attempts to determine whether oropharyngeal KS is associated with human herpesvirus 8 (HHV-8)...
  21. ncbi request reprint Emergency parotidectomy for penetrating zone III neck trauma
    Luc G Morris
    Division of Acute Care Surgery, New York Presbyterian Hospital, Columbia College of Physicians and Surgeons, 161 Fort Washington Ave, Herbert Irving Pavilion, HIP 8 808, New York, NY 10032, USA
    Arch Surg 142:1206-8. 2007
    ..The management of penetrating trauma to the parotid region,and relevant anatomy, are discussed...
  22. ncbi request reprint The changing demographics of head and neck squamous cell carcinoma in the United States
    Andrew G Sikora
    Department of Otolaryngology, New York University School of Medicine, New York, New York, USA
    Laryngoscope 114:1915-23. 2004
    ..During this time, substantial immigration from other countries has occurred, and the average lifespan has increased. We tested the hypothesis that these trends have altered the HNSCCA patient population...